Potential Interactions Between Antiarrhythmic Medication And The Automatic Implantable Cardioverter Defibrillator
- 1 May 1991
- journal article
- review article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 14 (5) , 898-904
- https://doi.org/10.1111/j.1540-8159.1991.tb04132.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Survival of Patients with the Automatic Implantable Cardioverter DefibrillatorPacing and Clinical Electrophysiology, 1988
- The automatic implantable cardioverter-defibrillator. Clinical experience, complications, and follow-up in 25 patientsArchives of internal medicine (1960), 1988
- Effect of Antiarrhythmic Drugs on Defibrillation Threshold: Case Report of an Adverse Effect of Mexiletine and Review of the LiteraturePacing and Clinical Electrophysiology, 1988
- The relationship between successful defibrillation and delivered energy in open-chest dogs: Reappraisal of the “defibrillation threshold” conceptAmerican Heart Journal, 1987
- Effect of quinidine and bretylium on defibrillation energy requirementsAmerican Heart Journal, 1986
- Effects of encainide and its metabolites on energy requirements for defibrillation.Circulation, 1986
- Drug‐Device Interactions: Clinical ConsiderationsPacing and Clinical Electrophysiology, 1985
- Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.Circulation, 1985
- Malignant ventricular tachyarrhythmias associated with the use of encainideAmerican Heart Journal, 1981
- Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugsAmerican Heart Journal, 1979